THOR指數輪換ETF THIR 深 滬
等待開盤 11-07 09:30:00 美东时间
32.02
-0.020
-0.06%
華盛通- 最 高32.255
- 今 開32.21
- 成交量 8826股
- 最 低 32.02
- 昨 收 32.04
- 總市值 1.86亿
- 52周最高 35.00
- 市盈率 靜 --
- 換手率 0.15%
- 52周最低 30.15
- 委 比 0.00%
- 總股本 581.98万
- 歷史最高 35.00
- 量 比 0.21
- 振 幅 0.73%
- 歷史最低 23.9466
- 每 手 1
- 風險率 1.09%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多COMPX REPORTS THIRD QUARTER 2026 RESULTS
CompX International Inc. reported third-quarter 2026 net sales of $44.0 million, up from $40.0 million in 2025, with operating income rising to $6.4 million from $4.8 million. Net income was $5.4 million, or $.44 per share, compared to $4.2 million, or $.34 per share, in 2025. For the first nine months of 2026, net sales reached $128.2 million, up from $120.6 million, with operating income at $22.4 million versus $17.0 million in 2025. Growth was...
11-04 21:15
Rapport Therapeutics Reports Third Quarter 2026 Financials and Provides Business Update
Rapport Therapeutics reported positive Phase 2 results for RAP-219 in bipolar mania, meeting primary and secondary endpoints with significant improvement in YMRS scores and tolerability. The company plans two Phase 3 trials in 2H 2027 and expects initial data from the FOS open-label safety trial in 4Q 2026. With $815.4 million in cash, Rapport is well-funded to advance its pipeline, including RAP-219 for epilepsy and bipolar mania, and RAP-641 fo...
11-04 12:00
FUTUREFUEL ANNOUNCES THIRD QUARTER 2026 RESULTS CONFERENCE CALL AND WEBCAST DATE
FutureFuel Corp. (NYSE: FF) announced it will release third quarter 2026 results after the U.S. market closes on November 9, 2026. A conference call to discuss financial results and recent developments will be held on November 10, 2026, at 11:00 a.m. ET. The call will be webcast on the company's Investor Relations website, with dial-in numbers provided for domestic and international participants. A replay will be available until November 25, 2026...
10-27 20:15
ITG, Inc. Announces Preliminary Third Quarter 2026 Results
ITG, Inc. reported preliminary Q3 2026 results with revenue of $461.5M (up 49% YoY) and Adjusted EBITDA of $64.5M (up 64% YoY), both exceeding outlooks. Full results and conference call are scheduled for November 10 and 11, 2026.
10-22 20:30
argenx Reports Third Quarter 2026 Financial Results and Provides Business Update
argenx reported strong third-quarter 2026 results, with VYVGART driving $1.7 billion in global product net sales, up 54% year-over-year and 13% quarter-over-quarter. The company advanced multiple clinical programs, including submitting an sBLA for VYVGART Hytrulo in IMNM and progressing empasiprubart's Phase 3 MMN data expected in December 2026. argenx also advanced FB102 to Phase 3 in celiac disease. Financially, the company achieved operating i...
10-22 05:00
FSI ANNOUNCES THIRD QUARTER 2026 REVENUE
Flexible Solutions International, Inc. (NYSE-AMERICAN: FSI) reported a 36% year-over-year increase in Q3 2026 revenue, rising to $14.35 million from $10.56 million in Q3 2025. The growth was attributed to full operations at the Panama factory, strong performance in the ENP division, and progress in food-grade production. Full financial results will be released on November 13, 2026, with a conference call scheduled for November 16, 2026.
10-19 13:00
